Jvion Revenue and Competitors

Atlanta, GA USA

Location

$8.9M

Total Funding

Estimated Revenue & Valuation

  • Jvion's estimated annual revenue is currently $1.8M per year.(i)
  • Jvion received $Undisclosed in venture funding in January 2019.
  • Jvion's estimated revenue per employee is $70,000
  • Jvion's total funding is $8.9M.

Employee Data

  • Jvion has 26 Employees.(i)
  • Jvion grew their employee count by 0% last year.

Jvion's People

NameTitleEmail/Phone
1
VP TechnologyReveal Email/Phone
2
VP Customer SuccessReveal Email/Phone
3
SVP, Partner StrategyReveal Email/Phone
4
Senior Director, Clinical ProductReveal Email/Phone
5
Senior Director, Growth EnablementReveal Email/Phone
6
Director, Data PlatformReveal Email/Phone
7
Chief Medical Information OfficerReveal Email/Phone
8
Data ScientistReveal Email/Phone
9
Senior Director Clinical DevelopmentReveal Email/Phone
10
Data ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$153.5M94917%N/A$2.1B
#2
$53.2M179N/AN/AN/A
#3
$70.4M402N/AN/AN/A
#4
$2.4M15N/AN/AN/A
#5
$5.4M59N/AN/AN/A
#6
$1M16-57%$18.6MN/A
#7
$0.5M7N/AN/AN/A
#8
$1.9M33N/AN/AN/A
#9
$2M20N/AN/AN/A
#10
$9.5M73N/AN/AN/A
#11
$46.6M15711%N/AN/A
#12
$75M422-10%$114MN/A
#13
$1.9M33N/AN/AN/A
#14
$3.8M33N/AN/AN/A
#15
$129.7M494N/AN/AN/A
#16
$5.2M450%N/AN/A
#17
$6.5M30N/AN/AN/A
#18
$13.5M93N/AN/AN/A
#19
$7.7M6111%N/AN/A
#20
$42.5M143N/AN/AN/A
Add Company

What Is Jvion?

Jvion's Cognitive Clinical Success Machine helps providers take the patient-specific actions that will improve health. Using its underlying Eigen Sphere engine, the machine goes beyond risk stratification to identify the factors (clinical and non-clinical) driving patient risk andmost importantlythe personalized, recommended actions that will change a patient's risk trajectory. The machine tells you if you can do something about a patient's risk and, if so, what to do to change the outcome. As a result, providers are better able to effectively and positively impact more patient lives, individualize interventions, and focus time and the right resources to the exact patients who need them.

keywords:Enterprise Software,Health It,Healthcare,Pharmaceuticals

$8.9M

Total Funding

26

Number of Employees

$1.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jvion News

2022-04-19 - Artificial Intelligence In Healthcare Service Market Size ...

... Market Size, Outlook And Forecast | IBM, Microsoft, Enlitic, Arterys, Atomwise, Freenome, Butterfly Network, Jvion, Apixio, Ayasdi.

2022-03-22 - HIMSS22: Jvion brings AI to NTT Data's platform; InterSystems ...

Jvion's flagship clinical intelligence system, the Jvion CORE, will integrate into NTT Data's Nucleus for Healthcare platform.

2022-03-22 - Jvion Brings AI-Powered Clinical Insights to NTT DATA's ...

What You Should Know: – NTT Data and Jvion have just announced a new partnership, which will bring Jvion's prescriptive intelligence...

2021-11-22 - Health Equity, Labor Shortages, Care in the Home, and Value-Based Care: Jvion Shares Predictions for How AI Will Continue to Shape Healthcare in 2022

2022 will be the year of bold action to address social determinants of health, and clinical AI will play a starring role in both understanding how these barriers drive disparities and directing the right resources to the right patients and populations. ATLANTA (PRWEB) November 22, 2021 Jvion, ...

2021-09-09 - Jvion Drives Adoption of Prescriptive Intelligence and Clinical AI with New Peer-Reviewed Results, Platform Integrations and SDOH Solutions

ATLANTA (PRWEB) September 09, 2021 Jvion, a leader in prescriptive analytics, has continued its growth in 2021 with new integrations and partnerships, peer-reviewed results, and social determinants of health solutions designed to help healthcare organizations manage patient populations holistic ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M26-26%N/A
#2
$2150M274%N/A
#3
$6.1M27N/AN/A
#4
N/A2833%N/A
#5
$5.3M28-3%N/A

Jvion Funding

DateAmountRoundLead InvestorsReference
2016-03-11$8.9MUndisclosedArticle
2019-01-04$UndisclosedUndisclosedJMI EquityArticle